Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruth

Showing results (261-270 of 335) with videos related to

Pageof 34
Sort By:
The American Journal of Psychiatry|May 3, 2002
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodiumLakshmi N Yatham, Peter F Liddle, I-Shin Shiah, et al.
Archives of General Psychiatry|August 4, 2010
Effects of expectation on placebo-induced dopamine release in Parkinson diseaseSarah C Lidstone, Michael Schulzer, Katherine Dinelle, et al.
Journal of Neurochemistry|February 3, 2009
Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging studyVesna Sossi, Katherine Dinelle, Geoffrey J Topping, et al.
Archives of Neurology|December 15, 2004
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesisChong S Lee, Michael Schulzer, Raúl de la Fuente-Fernández, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017Hossein Borghaei, Corey J Langer, Michael Millenson, et al.
Circulation Research|October 29, 2005
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itselfMark B Pepys, Philip N Hawkins, Melvyn C Kahan, et al.
Synapse (New York, N.Y.)|November 28, 2002
Age and severity of nigrostriatal damage at onset of Parkinson's diseaseRaúl De La Fuente-Fernández, Andrew S Lim, Vesna Sossi, et al.
The American Journal of Clinical Nutrition|February 12, 2016
Effects of community-based sales of micronutrient powders on morbidity episodes in preschool children in Western KenyaParminder S Suchdev, O Yaw Addo, Reynaldo Martorell, et al.
Neurology|May 1, 1986
PET studies of cerebral glucose metabolism in idiopathic torticollisA J Stoessl, W R Martin, C Clark, et al.
Transplantation Proceedings|February 1, 1997
Improved graft survival in 100 retransplant recipients following AHG-negative crossmatchingR H Kerman, B Susskind, J Slaton, et al.
Pageof 34

Showing results (261-270 of 335) with videos related to

Sort By:
Pageof 34
The American Journal of Psychiatry|May 3, 2002
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodiumLakshmi N Yatham, Peter F Liddle, I-Shin Shiah, et al.
Archives of General Psychiatry|August 4, 2010
Effects of expectation on placebo-induced dopamine release in Parkinson diseaseSarah C Lidstone, Michael Schulzer, Katherine Dinelle, et al.
Journal of Neurochemistry|February 3, 2009
Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging studyVesna Sossi, Katherine Dinelle, Geoffrey J Topping, et al.
Archives of Neurology|December 15, 2004
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesisChong S Lee, Michael Schulzer, Raúl de la Fuente-Fernández, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017Hossein Borghaei, Corey J Langer, Michael Millenson, et al.
Circulation Research|October 29, 2005
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itselfMark B Pepys, Philip N Hawkins, Melvyn C Kahan, et al.
Synapse (New York, N.Y.)|November 28, 2002
Age and severity of nigrostriatal damage at onset of Parkinson's diseaseRaúl De La Fuente-Fernández, Andrew S Lim, Vesna Sossi, et al.
The American Journal of Clinical Nutrition|February 12, 2016
Effects of community-based sales of micronutrient powders on morbidity episodes in preschool children in Western KenyaParminder S Suchdev, O Yaw Addo, Reynaldo Martorell, et al.
Neurology|May 1, 1986
PET studies of cerebral glucose metabolism in idiopathic torticollisA J Stoessl, W R Martin, C Clark, et al.
Transplantation Proceedings|February 1, 1997
Improved graft survival in 100 retransplant recipients following AHG-negative crossmatchingR H Kerman, B Susskind, J Slaton, et al.
Pageof 34